Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Selim Cellek

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
British Journal of Pharmacology|January 24, 2003
The Rho-kinase inhibitor Y-27632 and the soluble guanylyl cyclase activator BAY41-2272 relax rabbit vaginal wall and clitoral corpus cavernosumSelim Cellek
Nature Reviews. Urology|July 11, 2012
Challenges in sexual medicineSelim Cellek, Annamaria Giraldi
British Journal of Pharmacology|October 3, 2002
Purines and pyrimidines are not involved in NANC relaxant responses in the rabbit vaginal wallTom Ziessen, Selim Cellek
BJU International|November 20, 2014
Histone deacetylase inhibition: a new target for Peyronie's disease?Selim Cellek, David J Ralph
The Journal of Sexual Medicine|March 24, 2020
Unwinding Fibrosis in Peyronie's DiseaseMarcus M Ilg, Selim Cellek
Nature Reviews. Urology|June 17, 2026
Combination therapy for acute Peyronie' s disease: a success story of translation from bench to bedsideDavid J Ralph, Selim Cellek
British Journal of Pharmacology|January 30, 2002
Characterization of the non-nitrergic NANC relaxation responses in the rabbit vaginal wallTom Ziessen, Salvador Moncada, Selim Cellek
Drug Discovery Today|May 3, 2025
The role of cyclic adenosine monophosphate (cAMP) in pathophysiology of fibrosisSophie L Harding-Fox, Selim Cellek
Expert Opinion on Investigational Drugs|November 20, 2002
A Rho-kinase inhibitor, soluble guanylate cyclase activator and nitric oxide-releasing PDE5 inhibitor: novel approaches to erectile dysfunctionSelim Cellek, Rowland W Rees, Jas Kalsi
Asian Journal of Andrology|April 25, 2014
Solving a bottleneck in animal models of Peyronie's diseaseSelim Cellek, William Stebbeds, David J Ralph
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
British Journal of Pharmacology|January 24, 2003
The Rho-kinase inhibitor Y-27632 and the soluble guanylyl cyclase activator BAY41-2272 relax rabbit vaginal wall and clitoral corpus cavernosumSelim Cellek
Nature Reviews. Urology|July 11, 2012
Challenges in sexual medicineSelim Cellek, Annamaria Giraldi
British Journal of Pharmacology|October 3, 2002
Purines and pyrimidines are not involved in NANC relaxant responses in the rabbit vaginal wallTom Ziessen, Selim Cellek
BJU International|November 20, 2014
Histone deacetylase inhibition: a new target for Peyronie's disease?Selim Cellek, David J Ralph
The Journal of Sexual Medicine|March 24, 2020
Unwinding Fibrosis in Peyronie's DiseaseMarcus M Ilg, Selim Cellek
Nature Reviews. Urology|June 17, 2026
Combination therapy for acute Peyronie' s disease: a success story of translation from bench to bedsideDavid J Ralph, Selim Cellek
British Journal of Pharmacology|January 30, 2002
Characterization of the non-nitrergic NANC relaxation responses in the rabbit vaginal wallTom Ziessen, Salvador Moncada, Selim Cellek
Drug Discovery Today|May 3, 2025
The role of cyclic adenosine monophosphate (cAMP) in pathophysiology of fibrosisSophie L Harding-Fox, Selim Cellek
Expert Opinion on Investigational Drugs|November 20, 2002
A Rho-kinase inhibitor, soluble guanylate cyclase activator and nitric oxide-releasing PDE5 inhibitor: novel approaches to erectile dysfunctionSelim Cellek, Rowland W Rees, Jas Kalsi
Asian Journal of Andrology|April 25, 2014
Solving a bottleneck in animal models of Peyronie's diseaseSelim Cellek, William Stebbeds, David J Ralph
Pageof 6